A Study of IBI363 Alone or in Combination With Standard Treatment in People With Solid Tumor Cancer

Full Title

A Phase 2, Open-label, Multicenter Study of IBI363 (PD1-IL2m) Alone or in Combination with Standard of Care Therapy in Participants with Advanced Solid Malignancies

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Adam Schoenfeld’s office at 646-608-4042.

Protocol

26-014

Phase

Phase II (phase 2)

Investigator

Adam J. Schoenfeld

Co-Investigators

Rona Yaeger

Diseases

Colorectal Cancer
Lung Cancer › Lung Cancer, Non-Small Cell
Solid Tumors

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT06281678

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description